definiens: means, with respect to any Company Product, amounts received following Closing during the Commercialization Contingent Payment Period in cons ideration for the sales or distribution of the Comp any Product by or on behalf of Parent, its Affiliates, or Milestone Obligor, to third parties ( each, a ), less the following deductions ( without duplication, including for deductions taken in accordance with GAAP ), all in accordance with GAAP applied consistently wi th the policies, conventions, methodologies and pro cedures applied consistently, in each case, by Parent to re port revenue in its financial statements, including any such financial statements which may become filed with th e U.S. Securities and Exchange Commission : 10 ( a ) customary trade, cash and quantity discounts ac tually given ; ( b ) amounts repaid or credits or allowances actuall y given or made for rejection, defect, recall or return of Company Products or for retroactive price reductions and billing errors ; ( c ) price reductions, rebates, loyalty cards ( or ot her patient discount programs ) and chargeback provisions granted to managed health care organizat ions, pharmacy benefit managers ( or equivalents the reof ), national, state / provincial, local, and other govern ments, their agencies and purchasers and reimburser s, or to other trade customers, or deductions due to legisla tive actions by any Governmental Authority ; ( d ) costs of freight, insurance, storage, distribut ion, warehousing and other transportation charges to the extent included in the total amount invoiced ; ( e ) if included in the aggregate gross invoice pric e of such Company Product, sales or excise taxes, duties or other similar governmental charges ( including any tax such as a value added or simila r tax, and excluding any taxes based on, or in lieu of, in come ) relating to the sale of such Company Product, as adjusted for rebates and refunds ; ( f ) any invoiced amounts that are not collected by a Selling Party, including bad debts, provided that ( i ) any such amounts subsequently collected wi ll be included in Net Sales for the period in which collected, and ( ii ) any such allowance under this s ubsection ( f ) shall not exceed two percent ( 2 % ) of the gross amounts received for sales or distribution of Compa ny Products during the applicable period ; and ( g ) the portion of administrative fees paid during the relevant time period to group purchasing organization or pharmaceutical benefit managers rel ating to the sale of such Company Product